Zvavahera Chirenje, MD
Professor
Ob/Gyn, Reproductive Sciences
School of Medicine

• Professor (voluntary) University of Zimbabwe Faculty of Medicine & Health Sciences, Harare Zimbabwe
• Principal Investigator (PI) / Director for the University of Zimbabwe Clinical Trials Unit (UZ-UCSF CTU)

In 1994, Dr. Chirenje was one of the founding members of the US National Institutes of Health (NIH) funded University of Zimbabwe - Clinical Trials Research Centre (UZ-CTRC), formerly University of Zimbabwe - University of California, San Francisco (UZ-UCSF) Collaborative Research Programme in Women’s Health. At this facility he conducts pivotal HIV prevention clinical trials in women with particular emphasis on Pre-Exposure Prophylaxis (PrEP) and HIV vaccine development and was instrumental in the establishment of the first HIV vaccine research capacity in Zimbabwe in 2017.

He oversees a research unit with 276 employees in Harare, Zimbabwe and 5 support staff in San Francisco, CA, providing leadership that promotes high quality research for 4 NIH sponsored networks of ACTG, IMPAACT, HPTN and HVTN. Over the past 26 years, Dr Chirenje has overseen the development of a centralized research support unit that coordinates fiscal management and executes NIH protocols at the highest level of data capture and retention of participants with a solid track record of scientific publications that has assisted in policy implementation for Zimbabwe’s Ministry of Health

His long-standing research focus has included evaluating the optimal performance of cervical cancer screening tests in low resource settings, cervical cancer screening and impact of HIV on HPV infections among women, finding safe and effective biomedical HIV prevention interventions for women, STI testing and treatment. Dr. Chirenje was Principal Investigator for a large protocol that screened 11,000 women in Harare, which became an international milestone study demonstrating the effectiveness of visual inspection with acetic acid (VIA) in screening for cervical cancer in low resource settings. Areas of interest:

• Evaluation of cervical cancer screening & treatment modalities in low resource settings.
• Implementation of HPV vaccination & HPV testing programmes in low resource settings.
• Evaluation of best biomedical HIV prevention methods among women (conducting pivotal HIV prevention trials on PrEP).
• Conducting HIV vaccine safety & efficacy trials.
• Conducting COVID-19 vaccine safety & efficacy trials.

• Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
  The lancet. HIV 2022 Velloza J, Donnell D, Hosek S, Anderson PL, Chirenje ZM, Mgodi N, Bekker LG, Marzinke MA, Delany-Moretlwe S, Celum C
• Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
  Vaccine 2022 Prudden HJ, Achilles SL, Schocken C, Broutet N, Canfell K, Akaba H, Basu P, Bhatla N, Chirenje ZM, Delany-Moretlwe S, Denny L, Gamage DG, Herrero R, Hutubessy R, Villa LL, Murillo R, Schiller JT, …
• Patient experiences of living with cancer before interaction with palliative care services in Zimbabwe: A qualitative secondary data analysis.
  European journal of cancer care 2022 Dandadzi A, Chapman E, Chirenje ZM, Namukwaya E, Pini S, Nkhoma K, Allsop MJ
• Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence.
  EClinicalMedicine 2022 Liu G, Mugo NR, Bayer C, Rao DW, Onono M, Mgodi NM, Chirenje ZM, Njoroge BW, Tan N, Bukusi EA, Barnabas RV
• Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
  AIDS (London, England) 2022 Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, Nakabiito C, Mkhize B, Mirembe BG, …
• The IARC Perspective on Cervical Cancer Screening.
  The New England journal of medicine 2021 Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, Kupets R, Smith R, Arrossi S, Bendahhou K, Canfell K, Chirenje ZM, Chung MH, Del Pino M, de Sanjosé S, Elfström M, Franco EL…
• Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa.
  Frontiers in reproductive health 2021 Noguchi LM, Marrazzo JM, Richardson B, Hillier SL, Balkus JE, Palanee-Phillips T, Nair G, Panchia R, Piper J, Gomez K, Ramjee G, Chirenje ZM
• Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
  PloS one 2021 Dube Mandishora RS, Rounge TB, Fitzpatrick M, Christiansen IK, Ambur OH, Lagström S, Stray-Pedersen B, Tommasino M, Palefsky J, Chirenje ZM
• Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
  American journal of reproductive immunology (New York, N.Y. : 1989) 2021 Matubu AT, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL
• Treatment approaches for women with positive cervical screening results in low-and middle-income countries.
  Preventive medicine 2021 Wentzensen N, Chirenje ZM, Prendiville W
• Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
  The lancet. HIV 2021 Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, …
• Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings.
  AIDS and behavior 2021 Musara P, Milford C, Shapley-Quinn MK, Weinrib R, Mutero P, Odoom E, Mgodi NM, Chirenje ZM, Hanif H, Clark MR, Smit J, van der Straten A, Montgomery ET, Quatro Study Team
• Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: a cost analysis.
  BMC health services research 2020 Hughes CS, Brown J, Murombedzi C, Chirenda T, Chareka G, Mhlanga F, Mateveke B, Gitome S, Makurumure T, Matubu A, Mgodi N, Chirenje Z, Kahn JG
• Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
  BMC women's health 2020 Fitzpatrick M, Pathipati MP, McCarty K, Rosenthal A, Katzenstein D, Chirenje ZM, Pinsky B
• Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives.
  American journal of reproductive immunology (New York, N.Y. : 1989) 2020 Achilles SL, Meyn LA, Mhlanga FG, Matubu AT, Stoner KA, Beamer MA, Chirenje ZM, Hillier SL
• Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment.
  AIDS and behavior 2020 Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A
• Antenatal depression: an examination of prevalence and its associated factors among pregnant women attending Harare polyclinics.
  BMC pregnancy and childbirth 2020 Kaiyo-Utete M, Dambi JM, Chingono A, Mazhandu FSM, Madziro-Ruwizhu TB, Henderson C, Magwali T, Langhaug L, Chirenje ZM
• Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
  AIDS (London, England) 2020 Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-…
• Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effort.
  Journal of public health in Africa 2019 Zhou DT, Maponga CC, Madhombiro M, Dube A, Mano R, Nyamhunga A, Machingura I, Manasa J, Hakim J, Chirenje ZM, Mudzviti T, Nhachi C, Ma Q, DiFrancesco R, Masanganise R, Morse GD
• Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
  American journal of reproductive immunology (New York, N.Y. : 1989) 2019 Matubu A, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL
• Human papillomavirus genotype distribution in genital warts among women in Harare-Zimbabwe.
  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2019 Manyere NR, Dube Mandishora RS, Magwali T, Mtisi F, Mataruka K, Mtede B, Palefsky JM, Chirenje ZM
• Social harms in female-initiated HIV prevention method research: state of the evidence.
  AIDS (London, England) 2019 Montgomery ET, Roberts ST, Nel A, Malherbe M, Torjesen K, Bunge K, Singh D, Baeten JM, Marrazzo J, Chirenje ZM, Kabwigu S, Beigi R, Riddler SA, Gaffour Z, Reddy K, Mansoor LE, Nair G, Woeber K, …
• Understanding data and information needs for palliative cancer care to inform digital health intervention development in Nigeria, Uganda and Zimbabwe: protocol for a multicountry qualitative study.
  BMJ open 2019 Okunade K, Bashan Nkhoma K, Salako O, Akeju D, Ebenso B, Namisango E, Soyannwo O, Namukwaya E, Dandadzi A, Nabirye E, Mupaza L, Luyirika E, Ddungu H, Chirenje ZM, Bennett MI, Harding R, Allsop MJ
• Giant mucinous cystadenoma: a case report.
  Journal of medical case reports 2019 Gwanzura C, Muyotcha AF, Magwali T, Chirenje ZM, Madziyire MG
• Community-based self-collected human papillomavirus screening in rural Zimbabwe.
  BMC public health 2019 Fitzpatrick MB, El-Khatib Z, Katzenstein D, Pinsky BA, Chirenje ZM, McCarty K
• Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
  The Journal of infectious diseases 2019 Marrazzo JM, Rabe L, Kelly C, Richardson B, Deal C, Schwartz JL, Chirenje ZM, Piper J, Morrow RA, Hendrix CW, Marzinke MA, Hillier SL, VOICE Study Team
• End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
  Journal of the International AIDS Society 2019 Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, Mphili N, Musara P, Jaggernath M, Ju S, Smit J, Chirenje ZM, Doncel GF, van der Straten A
• hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019 Fitzpatrick MB, Dube Mandishora RS, Katzenstein DA, McCarty K, Weber J, Sahoo MK, Manasa J, Chirenje ZM, Pinsky BA
• A case of twin reversed arterial perfusion (TRAP) sequence managed conservatively.
  The Pan African medical journal 2019 Ziki EM, Chirenje ZM, Madziyire MG
• Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory.
  International journal of mycobacteriology 2019 Stephen S, Muzhizhizhi D, Dhibi N, Chidemo T, Samaneka W, Matubu TA, Hakim JG, Chirenje ZM
• Anal human papillomavirus infection in HIV-positive men and women at two opportunistic infections clinics in Harare, Zimbabwe.
  BMC public health 2018 Chinyowa S, Palefsky JM, Chirenje ZM, Makunike-Mutasa R, Munjoma M, Muguti GI
• The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe.
  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2018 Majangara R, Chirenje ZM, Gidiri MF
• HIV infection in patients with sexually transmitted infections in Zimbabwe - Results from the Zimbabwe STI etiology study.
  PloS one 2018 Kilmarx PH, Gonese E, Lewis DA, Chirenje ZM, Barr BAT, Latif AS, Gwanzura L, Handsfield HH, Machiha A, Mugurungi O, Rietmeijer CA
• The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study.
  Sexually transmitted diseases 2018 Chirenje ZM, Dhibi N, Handsfield HH, Gonese E, Tippett Barr B, Gwanzura L, Latif AS, Maseko DV, Kularatne RS, Tshimanga M, Kilmarx PH, Machiha A, Mugurungi O, Rietmeijer CA
• Impact of contraceptive initiation on vaginal microbiota.
  American journal of obstetrics and gynecology 2018 Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL
• How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe.
  AIDS and behavior 2018 Musara P, Montgomery ET, Mgodi NM, Woeber K, Akello CA, Hartmann M, Cheng H, Levy L, Katz A, Grossman CI, Chirenje ZM, van der Straten A, Mensch B, Microbicide Trials Network-003D Study Team
• Microbiology and clinical outcomes of puerperal sepsis: a prospective cohort study.
  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2018 Majangara R, Gidiri MF, Chirenje ZM
• Misreporting of contraceptive hormone use in clinical research participants.
  Contraception 2017 Achilles SL, Mhlanga FG, Musara P, Poloyac SM, Chirenje ZM, Hillier SL
• The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.
  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2017 Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, Karugaba P, Panchia R, Marrazzo J, Chirenje ZM, Parikh UM, VOICE Study Team
• Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
  Journal of medical virology 2017 Dube Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM
• Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.
  AIDS research and human retroviruses 2017 Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, …
• Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).
  Sexually transmitted diseases 2017 Chirenje ZM, Gundacker HM, Richardson B, Rabe L, Gaffoor Z, Nair GL, Mirembe BG, Piper JM, Hillier S, Marrazzo J
• Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
  Journal of women's health (2002) 2017 Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE
• Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population.
  PloS one 2016 Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, Munjoma MW, Gomo ZA, Chirenje ZM, Hakim JG
• Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?
  AIDS and behavior 2016 Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A
• Healthcare providers' perspectives on the acceptability and uptake of HPV vaccines in Zimbabwe.
  Journal of psychosomatic obstetrics and gynaecology 2016 Crann SE, Barata PC, Mitchell R, Mawhinney L, Thistle P, Chirenje ZM, Stewart DE
• An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.
  Journal of acquired immune deficiency syndromes (1999) 2016 Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM
• Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31].
  Contraception 2016 Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM
• Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.
  Journal of acquired immune deficiency syndromes (1999) 2016 Mirembe BG, Kelly CW, Mgodi N, Greenspan S, Dai JY, Mayo A, Piper J, Akello CA, Kiweewa FM, Magure T, Nakabiito C, Marrazzo JM, Chirenje ZM, Riddler SA, MTN-003B Protocol Team
• Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
  The New England journal of medicine 2016 Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, …
• Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
  Contraception 2015 Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM
• Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial.
  Journal of acquired immune deficiency syndromes (1999) 2015 Balkus JE, Nair G, Montgomery ET, Mishra A, Palanee-Phillips T, Ramjee G, Panchia R, Selepe P, Richardson BA, Chirenje ZM, Marrazzo JM
• Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
  The lancet. HIV 2015 Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo …
• Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.
  The Journal of infectious diseases 2015 Dai JY, Hendrix CW, Richardson BA, Kelly C, Marzinke M, Chirenje ZM, Marrazzo JM, Brown ER
• Factors associated with bone mineral density in healthy African women.
  Archives of osteoporosis 2015 Mgodi NM, Kelly C, Gati B, Greenspan S, Dai JY, Bragg V, Livant E, Piper JM, Nakabiito C, Magure T, Marrazzo JM, Chirenje ZM, Riddler SA, MTN-003B Protocol Team
• Tenofovir-based preexposure prophylaxis for HIV infection among African women.
  The New England journal of medicine 2015 Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, …
• Hematological and biochemical laboratory reference intervals for Zimbabwean adolescents.
  Clinical laboratory 2015 Gomani P, Matubu AT, Mujuru HA, Munjoma MW, Tinago W, Mandozana G, Hakim JG, Gomo ZA, Chirenje ZM
• Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.
  International journal of cancer 2013 Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM
• Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.
  The Journal of infectious diseases 2012 Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC, MTN Biomedical Sciences Working Group, HPTN 035 Protocol Team
• Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel.
  Journal of the International AIDS Society 2012 Chirenje ZM, Mâsse BR, Maslankowski LA, Ramjee G, Coletti AS, Tembo TN, Magure TM, Soto-Torres L, Kelly C, Hillier S, Karim A
• Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.
  AIDS (London, England) 2011 Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L, HIV …
• Cancer survival in Harare, Zimbabwe, 1993-1997.
  IARC scientific publications 2011 Chokunonga E, Borok MZ, Chirenje ZM, Nyabakau AM, Parkin DM
• Antiretroviral-based HIV prevention strategies for women.
  Expert review of anti-infective therapy 2010 Chirenje ZM, Marrazzo J, Parikh UM
• Compliance and loss to follow up of HIV negative and positive mothers recruited from a PMTCT programme in Zimbabwe.
  The Central African journal of medicine 2007 Kurewa NE, Munjoma MM, Chirenje ZM, Rusakaniko S, Hussain A, Stray-Pedersen B
• Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study.
  Journal of human lactation : official journal of International Lactation Consultant Association 2006 Israel-Ballard KA, Maternowska MC, Abrams BF, Morrison P, Chitibura L, Chipato T, Chirenje ZM, Padian NS, Chantry CJ
• HIV and cancer of the cervix.
  Best practice & research. Clinical obstetrics & gynaecology 2005 Chirenje ZM
• The CONRAD/WHO Update 2000 colposcopy manual: how well is it working?
  Journal of acquired immune deficiency syndromes (1999) 2004 Njoroge B, Chirenje ZM, Pandey B, Mirembe F, Joshi S, Low-Beer N, Maslankowski LA
• Bacterial vaginosis and intravaginal practices: association with HIV.
  The Central African journal of medicine 2004 Mbizvo ME, Musya SE, Stray-Pedersen B, Chirenje Z, Hussain A
• Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries.
  Bulletin of the World Health Organization 2003 Chirenje ZM, Rusakaniko S, Kirumbi L, Ngwalle EW, Makuta-Tlebere P, Kaggwa S, Mpanju-Shumbusho W, Makoae L
• Cancer of the cervix: knowledge, beliefs and screening behaviours of health workers in Mudzi District in Mashonaland East Province, Zimbabwe.
  The Central African journal of medicine 2003 Tarwireyi F, Chirenje ZM, Rusakaniko S
• Effect of HIV Disease in Treatment Outcome of Cervical Squamous Intraepithelial Lesions Among Zimbabwean Women.
  Journal of lower genital tract disease 2003 Chirenje ZM, Rusakaniko S, Akino V, Munjoma M, Mlingo M
• A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia.
  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2001 Chirenje ZM, Rusakaniko S, Akino V, Mlingo M
• Topical vaginal microbicides in HIV/STI prevention.
  The Central African journal of medicine 2001 Chirenje ZM
• Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.
  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2001 Blumenthal PD, Gaffikin L, Chirenje ZM, McGrath J, Womack S, Shah K
• Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites.
  Journal of acquired immune deficiency syndromes (1999) 2001 van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K
• The management of cervical intra-epithelial neoplasia.
  The Central African journal of medicine 2000 Chirenje Z
• Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women.
  Journal of acquired immune deficiency syndromes (1999) 2000 van de Wijgert JH, Chirenje ZM, Iliff V, Mbizvo MT, Mason PR, Gwanzura L, Shiboski S, Padian NS
• Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women.
  The Journal of infectious diseases 2000 van De Wijgert JH, Mason PR, Gwanzura L, Mbizvo MT, Chirenje ZM, Iliff V, Shiboski S, Padian NS
• HPV-based cervical cancer screening in a population at high risk for HIV infection.
  International journal of cancer 2000 Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV
• Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe.
  BJOG : an international journal of obstetrics and gynaecology 2000 Womack SD, Chirenje ZM, Blumenthal PD, Gaffikin L, McGrath JA, Chipato T, Ngwalle E, Shah KV
• Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study.
  The Central African journal of medicine 1999 Chirenje ZM, Chipato T, Kasule J, Rusakaniko S
• Situation analysis for cervical cancer diagnosis and treatment in Zimbabwe.
  The Central African journal of medicine 1998 Chirenje ZM, Rusakaniko S, Chipato T, Mpanju-Shumbusho W, Ngwalle E, Kirumbi LW, Makuta-Tlebere P, Kaggwa S
• Cervical cancer screening in a rural population of Zimbabwe.
  The Central African journal of medicine 1997 Thistle PJ, Chirenje ZM
• Management of the patient with an abnormal Papanicolaou smear.
  The Central African journal of medicine 1994 Chirenje ZM
• Screening for cervical cancer: experience from the Colposcopy Clinic at Harare Hospital.
  The Central African journal of medicine 1993 Chirenje ZM, Akino V